OncologyInformationService
Real World Databases
Evidence based Healthcare and Market Research
Why choose O.I.s)
Expert in Oncology
Expert in Healthcare Market Research
Warranty of Quality
International Team
Solutions
Solutions
Real World Data (TherapieMonitor)
Real World Evidence (Non-Interventional studies)
Evidence based Market Assessment & Dynamics (OncoRegioPanel)
Epidemiology, Healthcare Structure Research
References
Publications
Endorsements
Team
O.I.s) Family
Want to join us?
Current Projects
TherapieMonitor (RealWorldData)
TherapieMonitor Malignes Melanom 4. Quartal 2018
International TherapieMonitor Multiple Myeloma refractory/relapsed 2018
Österreich: TherapieMonitor Multiple Myeloma refractory/relapsed 2017 AT
BE: TherapieMonitor Multiple Myeloma refractory/relapsed 2018 Belgique/België
CH: TherapieMonitor Multiple Myeloma refractory/relapsed 2018 Schweiz/Suisse/Svizzera
ES: TherapieMonitor Multiple Myeloma refractory/relapsed 2018 España
GR: TherapieMonitor Multiple Myeloma refractory/relapsed 2018 Ελλάδα
UK: TherapieMonitor Multiple Myeloma refractory/relapsed 2018 United Kingdom
FR: TherapieMonitor Multiple Myeloma refractory/relapsed 2018 France
National: TherapieMonitor Multiples Myelom 4. Quartal 2018
TherapieMonitor NSCLC IIIb-IV 4. Quartal 2018
TherapieMonitor HGS Ovarialkarzinom 4. Quartal 2018
TherapieMonitor Urothelkarzinom Stadium IV 4. Quartal 2018
OncoRegioPanel Survey
OncoPanel Therapie des Mammakarzinoms Q4 2018
OncoPanel fortgeschrittenes Pankreaskarzinom im 4. Quartal 2018
O.I.s) OncoPanel NSCLC IIIb/IV im 4. Quartal 2018
O.I.s) OncoPanel Therapie des malignen Melanom im 4. Quartal 2018
Are you interested to participate?
Imprint
Abmeldung Aktuelle Online-Erhebung
Wir werden Ihren Wunsch berücksichtigen.